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Abstract 
Objective: In rats, pulmonary resection is followed by lung compensatory growth. 
However, the molecular mechanism underlying lung compensatory growth remains 
unclear. Keratinocyte growth factor (KGF) is expressed in lung tissue and is considered a 
possible mitogen for lung epithelial cells. The objectives of this study were to define the 
role of KGF and its receptor (KGFR) in rat lung compensatory growth after trilobectomy 
and the effect of exogenous KGF expression gene transfection.  
Methods: Adult Lewis rats were used. Right trilobectomy was performed in operation 
group and sham thoracotomy in sham group. In operation group, KGF-FLAG or FLAG 
expression vector was transfected directly into the lung by electroporation. Expression of 
KGF and KGFR, and alveolar cell proliferation index using proliferating cell nuclear 
antigen (PCNA) were measured in the right lung at day 14 after operation.  
Results: PCNA, KGF and KGFR expressions in lung epithelial cells were significantly 
increased at day 4 after trilobectomy. Transfection of KGF-FLAG expression vector 
resulted in further significant enhancement of PCNA at day 4 after trilobectomy; however, 
the transfection of FLAG expression vector did not alter the enhancement of PCNA. 
Exogenous expression of KGF in remnant lung by electroporation significantly 
augmented epithelial proliferation and decreased the average air space distance [mean 
linear intercept (Lm)]. 
Conclusion: Our results implicate KGF in the induction of alveolar epithelial cell 
proliferation for compensatory lung growth, and that overexpression of KGF in remnant 
lung by electroporation significantly augmented lung epithelial proliferation.  
 
Word count; 239 words 
 
Ultramini-abstract: KGF is a member of fibroblast growth factor family. In rats 
subjected to trilobectomy, PCNA, KGF and KGF-R were overexpressed in lung epithelial 
cells of remnant lung 4 days later. KGF gene transfection by electroporation in remnant 
lung significantly augmented epithelial proliferation and reduced the average air space 
distance.  




The lung undergoes compensatory growth after lung injury or surgical resection. 
The growth process involves increasing lung volume, weight, cell proliferation and 
pulmonary function (1, 2), but the mechanism responsible for this process is unclear. 
Understanding lung compensatory growth requires clarification of the molecular 
mechanism underlying the induction of lung epithelial cell proliferation.  
Rubin et al. (3) discovered keratinocyte growth factor (KGF) as a mesenchymal 
cell-derived epithelial cell mitogen and subsequently, the KGF receptor (KGFR; bek IIIb) 
was identified in various epithelial cells. KGF expression is upregulated in rodent models 
of lung injury and has been implicated in the induction of alveolar epithelial cell 
proliferation (4). Kaza et al. (5) demonstrated that exogenous KGF enhanced 
postpneumonectomy compensatory lung growth through alveolar proliferation. The 
findings of that study were significant for investigating the role of exogenous KGF on 
lung compensatory growth. However, it is still unclear whether endogenous KGF and 
KGFR play a direct role in the induction of lung epithelial proliferation and 
differentiation during the compensatory growth of lung following lobectomy. 
We hypothesized that KGF and KGFR are involved in compensatory lung growth 
and that exogenous KGF administration accelerates the compensatory lung growth. In the 
present study, we investigated first the temporal and spatial relationships between 
proliferation of lung epithelial cells and expression of KGF/KGFR in regenerating rat 
lung after trilobectomy by using immunohistochemistry. In the second part of the study, 
 
KGF was expressed in remnant lung tissue to examine the effect of prolonged exposure 
to KGF on lung growth in vivo. For prolonged in situ expression of KGF in the lung, we 
used electroporation in this study because, unlike other methods, it facilitates the 
introduction of foreign genes into a specific area of the desired tissue with minimal 
damage (6), and with few side effects.
 
Materials and Methods 
 
Animals, surgical procedure, and tissue preparation 
Pathogen-free 8-week-old male Lewis rats weighing 220–270 g used as adult rats were 
purchased from Charles River Japan (Kanagawa, Japan). Each rat was anesthetized with 
intraperitoneal injection of 25 mg/kg sodium pentobarbital. The right lung of rats consists 
of four lobes; the cranial, middle, accessory and caudal lobe. In the surgery group, the 
right three lobes (cranial, middle and accessory lobe) were excised by thoracotomy while 
the remnant caudal lobe was used for investigation. In the sham group, a simple right 
thoracotomy was performed. Each experimental group at a given time point consisted of 
three rats. The remnant lung lobe after trilobectomy and sham-operation were dissected 
out and fixed with 4% paraformaldehyde (Merck, Darmstadt, Germany). Serial 4-μm 
sections were cut and each specimen was stained with hematoxylin and eosin. All animal 
experiments were performed in accordance with NIH guidelines dictated by the Animal 




L2 rat lung epithelial cells (ATCC, Manassas, VA) were grown in F12K medium (Sigma, 
St. Louis, MO) supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, and 
10% fetal bovine serum at 37°C and 5% CO2.  
 
 
Construction of a recombinant plasmid encoding human KGF 
The human KGF (hKGF) coding region was amplified by polymerase chain reaction 
(PCR) using pCEV9 plasmid (kindly provided by Jeffrey Rubin, National Cancer 
Institute, Bethesda, MD) as template. This plasmid contains the complete KGF coding 
sequence isolated from an M426 human embryonic lung fibroblast cDNA library (7). The 
sequences of forward and reverse primers were 
5’-CCTAGATCTGCCACCATGCACAAATGGATACTGAC-3’ and 
5’-CCTCTCGAGTTAAGTTATTGCCATAGGAAG-3’, respectively. The forward 
primer is homologous to nucleotides 1 to 20 in the hKGF open reading frame and 
contains a consensus (GCCACC) Kozak sequence immediately upstream of the initiation 
codon. In addition, a BglII site was inserted at the 5’-end to facilitate cloning. The reverse 
primer is homologous to nucleotides 563 to 582 and contains an XbaI site at the 
5’-terminus. These primers allowed amplification of a 603-bp cDNA fragment. PCR was 
carried out in a reaction mixture containing 2 mM Tris-HCl, pH 8.0, 10 mM KCl, 2 mM 
MgCl2, 0.01 mM ethylenediaminetetraacetic acid (EDTA), 0.1 mM dithiothreitol (DTT), 
0.05% Tween 20, 0.05% nonidet P-40, 5% glycerol, 0.25 mM dNTP mixture, 100 pmol 
of each primer, 6 μg pCEV9 DNA, and 3 U Taq polymerase (Takara Mirus Bio Co, 
Shiga, Japan). Before cycling, the mixture was divided into four 20-μl reaction volumes. 
PCR assays were performed in a Gene Amp PCR system 9600 (Perkin Elmer, Foster City, 
CA) for 27 cycles under the following conditions: 94°C for 30 s, 54°C for 30 s, and 72°C 
for 1 min, followed by a final extension at 72°C for 15 min. Agarose gel electrophoresis 
using a Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany) was used to purify the 
 
amplified product. The recovered DNA was then cloned into the plasmid pGEM-T Easy 
Vector using pGEM-T Easy Vector System I (Promega, Madison, WI), resulting in the 
pGEM-hKGF plasmid. We then isolated the DNA insert containing the hKGF sequence 
from pGEM-hKGF by double digestion with BglII and XbaI and further subcloned into 
the p3xFLAG-CMV14 vector (Sigma) at the same restriction sites to produce the 
pKGF-FLAG plasmid. All constructions were confirmed by automated sequencing 
(CEQ8000; Beckman Coulter, Fullerton, CA). 
 
Evaluation of lung cell proliferation  
Lung cell proliferation was analyzed immunohistochemically using anti-proliferating cell 
nuclear antigen (PCNA) antibody (DAKO, Glostrup, Denmark). Briefly, the sections 
were autoclaved and incubated with PCNA (1:200) as the primary antibody and 
horseradish peroxidase (HRP)-goat anti-mouse IgG (1:200) (Chemicon International 
Temecula, CA) as the secondary antibody. 
  
Western blot analysis of KGF and KGFR expression in transfected cells and 
remnant lung tissue 
Transfected cells were lysed in 0.3 ml of lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM 
NaCl, 5 mM EDTA, 1 mM phenylmethylsulfonylfluoride, 50 μg/ml lima bean trypsin 
inhibitor, and 0.5% Triton X-100). Rat lung specimens were homogenized in lysis, 
centrifuged, and then the supernatants were collected. Recombinant human KGF (rhKGF, 
Pepro Tech EC, London, UK) and recombinant human KGFR (rhKGFR, R&D Systems 
 
Minneapolis, MN) were also processed as positive controls. Samples were separated by 
SDS-PAGE on a 4–20% gradient gel (Daiichi Pure Chemicals, Tokyo, Japan) for KGF or 
a 10–20% gradient gel (Daiichi) for KGFR and electrophoretically transferred to 
polyvinylidene difluoride membrane (Immobilon, Millipore Corporation, Bedford, MA). 
The membranes were blocked with Blocking One (Nacalai tesque, Kyoto, Japan) and 
then incubated with the first antibody (1:800 anti-KGF antibody, 1:800 anti-KGFR 
antibody; Nichirei Co, Tokyo, Japan, and 1:6000 peroxidase-conjugated mouse 
monoclonal anti-FLAG antibody; Invitrogen, Tokyo, Japan). After washing, the 
membranes were reacted with HRP-conjugated goat anti-rabbit IgG as the secondary 
antibody at 1:8,000 for KGF and 1:4,000 for KGFR, and were visualized by 
chemiluminescence using the ECL Plus reagent (Amersham Biosciences, Piscataway, 
NJ). 
 
Immunohistochemistry of KGF and KGFR in the lung 
Immunohistochemistry was performed to determine the expression of KGF and KGFR in 
tissue sections using anti-KGF and anti-KGFR antibodies as described previously (8, 9). 
Sections of rat lung tissue were incubated for 2 hours with primary antibody at 1.0 μg/ml 
for the anti-KGF antibody and 1:600 for anti-KGFR antiserum, then incubated with 
HRP-conjugated goat anti-rabbit IgG (1:100) (MBL, Nagoya, Japan) for 1 hour. After 
washing, HRP sites were visualized by treatment with 3,3’-diaminobenzidine-4HCl 
(DAB; Dojindo, Kumamoto, Japan) and H2O2.  
 
Transfection of KGF expression plasmid into cultured cells and assay of cell 
proliferation and KGF production 
L2 cells (2 x 106 in 200 μl) were resuspended into sterile cuvettes, and plasmid DNA (10 
μg) of pKGF-FLAG or pFLAG gene was added. An electric pulse (400 V, 99 μsec, five 
pulses) was delivered to the cells, using a BTX Transfector apparatus (BTX Inc, San 
Diego, CA). To determine the biological activity of KGF-FLAG fusion protein in vitro, 
cells were plated at a density of 3 x 103 cells/well in 96-well plates at a final volume of 
100 μl/ well, and cultured in a humidified atmosphere at 37°C for analysis using the Cell 
Proliferation Biotrak enzyme-linked immunosorbent assay (ELISA) system (Amersham 
Biosciences). The optical density of each well was measured at 450 nm.  
To measure KGF, the cells were plated at a density of 5 x 105 cells/well in 6-well 
plastic culture dishes (Iwaki, Tokyo) in 1 ml of F12K medium (Sigma) supplemented 
with 10% fetal bovine serum per well. After incubation for 24, 48, or 72 hours, the media 
were collected and the cells harvested with a lysate buffer (1% SDS and 1.0 mM sodium 
orthovanadate in 10 mM Tris-HCl, pH 7.4). The concentration of KGF was determined 
by ELISA (R&D Systems), according to the instructions provided by the manufacturer. 
 
In vivo transfection of KGF-FLAG and FLAG expression vectors 
For tissue transfection, pulses generated with an Electro Square Porator (T820; BTX) 
were delivered to the organ by a pair of electrode disks (1-cm diameter) attached to the 
tips of tweezers (Pinsettes-Type electrode 449-10PRG; Meiwa Shoji, Tokyo). We used a 
 
green fluorescent protein (GFP)-expressing plasmid to optimize conditions for lung 
transfection. The best results were obtained with six pulses of 50 V for 50 μsec each 
separated by 999 msec, delivered by electrode disks separated by approximately 5 mm 
(data not shown). After trilobectomy, a solution of 100 μg of pKGF-FLAG or pFLAG 
plasmid in 100 μl PBS was injected directly with a 29-gauge needle into remnant lung 
between the electrode disks. Immediately after the DNA injection, electric pulses were 
administered. Rats were sacrificed 2, 4, or 7 days after electroporation, Each 
experimental group consisted of five rats at each time point. 
 
Identification of PCNA-positive and FLAG-expressing cell types  
Double staining for PCNA and SP-A, an alveolar type II epithelial cell marker, was 
performed on sections of lung tissue to identify the types of PCNA-positive cells. The 
slides were stained first with anti-SP-A antibody (Santa Cruz Biotechnology, Santa Cruz, 
CA; 1:30) and the HRP sites were visualized with DAB and H2O2. The slides were 
autoclaved and immersed three times with 0.1 M glycine-HCl buffer (pH 2.2) and then 
immunostained with anti-PCNA antibody (1:50), as described above. HRP reactivity was 
visualized with 4-Cl-1-naphthol (Tokyo Kasei Kogyo, Tokyo). Peroxidase-conjugated 
mouse monoclonal anti-FLAG antibody (Invitrogen; 1:30) was used to identify 




The PCNA staining was graded as positive or negative, compared to the negative control. 
For each section, more than 2,000 cell nuclei were counted over randomly selected fields 
at x 400 magnification. The number of positive cells was expressed as the percentage of 
cells with positive nuclei per total number of counted nuclei (10). The signal density of 
KGF and KGFR per cell was measured by an image analyzer, and calculated from the 
sum of the gray values of all pixels corresponding to the cell. 
Using a grid with lines of known length, the average air space distance [mean 
linear intercept (Lm)] was determined in 30 randomly selected microscopic fields per 
each rat in pFLAG gene- or pKGF-FLAG gene-transfected group at day 7 after operation. 
The observers that performed the measurements were blinded to the experimental groups. 
 
Statistical analysis 
Data are expressed as mean ± SEM. Differences between groups were examined for 
statistical significance using unpaired Student’s t-test or one-way analysis of variance. A 
P value <0.05 was considered statistically significant. All analyses were performed with a 




Induction of epithelial cell proliferation in remnant lung after trilobectomy 
To examine the cell kinetics of compensatory regenerating lung, proliferating cells were 
assessed by immunochemical staining for PCNA. A few proliferating cells were noted in 
the normal lung (Figure 1A and B), with a PCNA labeling index (% of proliferative cells 
per total cell number) of 1.74 ± 0.75 for alveolar epithelial cells. At day 4 after 
trilobectomy, several PCNA-positive bronchial and alveolar epithelial cells were noted 
(Figure 1C and D), with a PCNA labeling index of 8.49 ± 1.83 for alveolar epithelial 
cells. In the sham-operation lung, few PCNA-positive bronchial and alveolar epithelial 
cells were detected (Figure 1E and F), with a PCNA labeling index of 1.99 ± 0.61 for 
alveolar epithelial cells. Most of the positive cells in the alveolar regions of trilobectomy 
rats seemed to be alveolar type II epithelial cells (Figure 1C). As shown in Figure 1G, the 
percentage of PCNA-positive cells increased significantly at day 2, and reached 
maximum at day 4 after operation in the trilobectomy group. Many PCNA-positive cells 
were alveolar type II cells (Figure 1C), however, some alveolar type I cells, macrophages, 
fibroblasts, bronchial epithelial cells were PCNA-positive. 
 
Western blot analysis of KGF and KGFR expression in remnant lung after 
trilobectomy 
Western blot analysis showed specific bands corresponding to KGF and KGFR proteins 
at approximately 28 kDa and 130 kDa, respectively (3, 11, 12). The Approximate 
 
molecular mass of 130 kDa is agreement with the reported molecular mass of the mature 
KGFR (11-13). Recombinant human KGF is an 18.9-kDa protein containing 163 amino 
acid residues, but has the same function as endogenous KGF. The reduced human KGFR 
has a calculated molecular mass of approximately 56 kDa. As a result of glycosylation, 
the recombinant protein migrates as an approximately 100 kDa protein in SDS-PAGE. 
The intensity levels of the KGF and KGFR bands in remnant lung markedly increased at 
day 4 after trilobectomy, compared with the sham-operation group (Figure 2).  
 
Immunohistochemical localization of KGF and KGFR in remnant lung after 
trilobectomy 
Normal lung collected after the sham operation showed KGF protein expression only in a 
few stromal cells and alveolar epithelial cells, particularly alveolar type II cells (data not 
shown). KGFR was also found in only a few epithelial cells. The expression of both KGF 
and KGFR increased following the trilobectomy, compared with the sham-operation lung 
(Figure 3B and D) and reached a maximum in the alveolar (Figure 3A and C) and 
bronchial regions (Figure 3E and F) at day 4 after operation. KGF was expressed strongly 
in stromal cells, alveolar type I, and type II cells, while KGFR was expressed only in 
epithelial cells, especially alveolar type II cells, where the signal was distributed in the 
cytoplasm and plasma membrane. KGF expression increased as early as day 2 after 
trilobectomy in remnant lung tissue (signal density in operation group; 3.92 ± 1.05-fold, 
sham operation group; 1.05 ± 1.11-fold, P <0.05) and reached a maximum at day 4 after 
operation (signal density in operation group; 9.16 ± 4.38-fold, sham operation group; 
 
0.84 ± 0.33-fold, P <0.05), as shown in Figure 3G. Similarly, KGFR expression reached 
a maximum at day 4 after trilobectomy (signal density in operation group; 22.96 ± 
13.6-fold, sham operation group; 0.91 ± 0.30-fold, P <0.05), as shown in Figure 3H. 
To clarify the relationship between PCNA-positive cells and KGF- or 
KGFR-positive cells, these antigens were localized in serial sections (Figure 4). KGF and 
KGFR were detected in both alveolar type I and type II cells, while PCNA was localized 
in alveolar type II cells. 
 
Enhancement of KGF expression and proliferating activity in cultured rat lung 
epithelial cells (L2 cells) expressing the pKGF-FLAG gene 
L2 cells were transfected with pKGF-FLAG cDNA and the concentration of KGF-FLAG 
protein in the lysates and culture medium was measured at various time points (Figure 
5A). KGF concentration in the medium increased in a time-dependent manner, while that 
in the lysates was unchanged.  
Next, BrdU uptake by L2 cells transfected with pKGF-FLAG or pFLAG plasmids 
was measured to assess the DNA synthetic activity (Figure 5B). After 24 hours of 
transfection, BrdU uptake increased significantly in pKGF-FLAG-transfected cells 
(P=0.0003), although there was no significant difference in cell numbers (Figure 5C). 
After 72 hours, however, the increase in cell number became significant (Figure 5C), 
while no significant difference was measured in the rate of BrdU uptake. These results 
indicated that the KGF expression vector used in the present study worked well in lung 
epithelial cells and that the expressed KGF was active in stimulating cell proliferation. 
 
 
Effect of augmented KGF expression driven by pKGF-FLAG transfection on 
compensatory growth of remnant lung after trilobectomy 
PCNA expression was then examined in remnant lung transfected with pKGF-FLAG or 
pFLAG following trilobectomy to assess the effect of prolonged exposure to KGF on 
compensatory lung growth process. As shown in Figure 6A and B, the number of 
PCNA-positive cells markedly increased in remnant lung transfected with pKGF-FLAG 
compared to that overexpressing pFLAG alone. In fact, immunohistochemistry of the 
pKGF-FLAG-transfected lung revealed a higher abundance of PCNA-positive cells 
(Figure 6D) in areas strongly stained for FLAG (Figure 6C) than in FLAG-negative areas 
(data not shown). Quantitative analysis of PCNA-positive cells also revealed a significant 
increase in remnant lung transfected with pKGF-FLAG (Figure 6E). Figure 6F shows Lm 
values measured in the two experimental groups at day 7 after operation. Rats transfected 
with pKGF-FLAG gene showed a significant decrease in the mean values of Lm 
(P<0.001) compared with rats transfected pFLAG gene. 
Finally, PCNA-positive cells in the pKGF-FLAG-transfected lung comprised 
predominantly alveolar epithelial cells with some fibroblasts, endothelial cells, 
macrophages and bronchial epithelial cells. To correlate the PCNA-positive cells with 
alveolar epithelial cell-type, we double-stained for PCNA and SP-A (a marker for 
alveolar type II cells). SP-A-positive cells also expressed PCNA. Interestingly; however, 
some SP-A-negative epithelial cells were also positive for PCNA, indicating that alveolar 
type I cells could proliferate under these experimental conditions (Figure 7). Interestingly, 
 
in remnant lung after trilobectomy only, a few cells excluding alveolar type II cells were 
proliferative (Figure1C). However, in remnant lung after trilobectomy and gene 
transfection, many cells, including type I cells, macrophages, fibroblasts and bronchial 




The present study investigated the possible roles of KGF in the regulation of rat lung 
compensatory growth after right trilobectomy, and found that in parallel with more 
PCNA-positive alveolar type II cells, the expression levels of KGF and KGFR were 
increased in the remnant lung. In particular, the expression of KGFR was markedly 
induced after trilobectomy in alveolar epithelial cells, and such expression might be 
involved in the induction of proliferation of alveolar type II cells. Moreover, when the 
KGF-FLAG expression vector was expressed in remnant lung by electroporation, the 
fusion protein was effectively produced in various cells. In addition, the transfected lung 
showed significantly enhanced proliferation activity and possible alveolar septation. 
These results strongly implicate KGF in the induction of alveolar epithelial cell 
proliferation for compensatory growth of the lung, and that in vivo overexpression of 
KGF seems to accelerate KGF-dependent compensatory growth processes in organs.  
A number of studies have documented that pulmonary alveoli are capable of 
regeneration. In rodents, retinoid acid enhanced lung growth after pneumonectomy in rats 
(1) and estradiol induced alveolar regeneration after loss of alveoli induced by 
ovariectomy in adult mice (14). These studies described increased cell proliferation, lung 
volume, lung weight, alveolar surface density and alveolar number in experimental 
animals. Unfortunately, it is impossible to conduct the above assessments in human, 
instead these tests are limited to pulmonary function tests, especially, forced vital 
capacity and FEV1. Thus, there is so far no documented evidence for lung regeneration in 
 
human. However, based on the present and previous animal experiments, further 
advances in medical biotechnology could perhaps allow investigation of this process in 
human.  
The KGF-KGFR system also plays an important role in lung epithelial cell 
turnover in normal rodents. Many studies showed that administration of recombinant 
KGF could mimic the proliferation of alveolar type II cells both in vitro and in vivo (15, 
16). Importantly, Kaza et al. (5) demonstrated that recombinant KGF enhances 
post-pneumonectomy lung growth accompanied by alveolar cell proliferation, similar to 
the present results. However, they did not deal with the involvement of KGFR, which is 
also an essential factor in the logical understanding of the role of KGF in compensatory 
lung growth. The present work demonstrates the involvement of both KGF and KGFR in 
the induction of compensatory lung growth. In fact, KGF has been implicated in various 
phenomena (8, 17), where a low level of constitutive KGFR expression might be 
sufficient for the necessary action of KGF. The present study showed that PCNA, KGF, 
and KGFR were simultaneously localized in the same alveolar type II cells at day 4 after 
trilobectomy. However, there was an apparent difference in the appearance of PCNA- 
and KGFR-positive cells, and it should be noted that several other factors such as basic 
fibroblast growth factor (18), hepatocyte growth factor (19, 20) and epidermal growth 
factor (21), and VEGF (22) might also play a role in lung growth. 
Basic fibroblast growth factor (bFGF) induces an increase in pulmonary blood 
flow in the damaged lung (18). HGF is a potent mitogen for rat alveolar epithelial cells, 
especially alveolar type II cells (19) and may work simultaneously on various types of 
 
cells. However, HGF alone was found to be incapable of restoring branching 
morphogenesis, unlike KGF and acidic FGF. HGF exhibits synergistic effects with KGF 
or acidic FGF in this mesenchyme-free system (20). EGF stimulates the 
cytodifferentiation of alveolar type II cells and biosynthesis of surfactant precursor 
proteins (21). Furthermore, it has been demonstrated that during pulmonary distension, 
the stimulus for alveolarization (capillary and alveolar growth) upregulated VEGF 
mRNA (22). Finally, it is unlikely that each of the above factors can singularly enhance 
lung growth; rather, the synergistic effects of mediators of mesenchymal-epithelial 
interactions are more likely to be important in lung growth. 
The present study applied electroporation to maximize the transfection efficiency 
so that a single-dose regimen could be used and much smaller amounts of DNA would be 
required. One major advantage of electroporation for gene transfection into the lung is 
that it efficiently transfers cDNA to multiple cell types simultaneously including alveolar 
epithelial cells, bronchial epithelial cells, smooth muscle cells, endothelial cells, and 
other cells in focal or target areas of the lung. In the present study, in remnant lung after 
trilobectomy only, a few cells excluding alveolar type II cells were proliferative (Figure 
1C), however, in remnant lung after trilobectomy and gene transfection, many cells, 
including type I cells, macrophages, fibroblasts and bronchial cells were proliferative, 
especially alveolar type II cells (Figure 6B and 6D).  
The significantly elevated PCNA index in remnant lung after trilobectomy was 
seen by day 2 after transfection and continued until day 4, before returning to the control, 
untransfected level at day 7. Yew et al. (23) reported increased duration of expression of 
 
up to 3 months with a human ubiquitin B promoter or a hybrid CMV–ubiquitin B 
promoter. In the present study, we are not sure that a long-term expression of KGF is 
beneficial or not. However, these alternative promoters might be tested for their effects 
on both duration and level of gene expression in our system. On the other hand, at day 7 
after operation, rats transfected pKGF-FLAG gene showed a significant decrease in the 
mean values of Lm compared with rats transfected with pFLAG gene (p<0.001). In spite 
of the short duration of gene expression, these data support the possibility of alveolar 
septation and increased number of alveoli in the pulmonary parenchyma. 
In conclusion, our results showed the potential involvement of endogenous KGF 
in compensatory tissue growth in adult rat lung. Moreover, direct injection of naked DNA 
coupled with electroporation seemed to significantly enhance compensatory lung growth. 
Although more work needs to be done, we believe this study advocates gene therapy as a 
potential tool to accelerate tissue growth in adult rat lung.
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Figure 1. Serial changes in PCNA-positive alveolar epithelial cell counts in remnant 
lung.  
(A-F) Immunohistochemical staining for PCNA. Magnification: x400. Bar: 50 μm (A) 
Alveolar part in normal lung. (B) Bronchial part in normal lung. (C) Alveolar part at day 
4 after trilobectomy. (D) Bronchial part at day 4 after trilobectomy. (E) Alveolar part at 
day 4 after sham-operation. (F) Bronchial part at day 4 after sham-operation. (G) Serial 
changes in PCNA labeling index. Open circles: trilobectomy group (n=3), closed circles: 
sham group (n=3) (*p<0.05).  
   
Figure 2. Western blot analysis of KGF and KGFR in remnant lung. 
Recombinant human KGF (rhKGF) protein (lane 1), lysates of remnant lung at day 4 
after trilobectomy (lane 2) and after sham-operation (lane 3). Recombinant human KGFR 
(rhKGFR) protein (lane 4), lysates of remnant lung at day 4 after trilobectomy (lane 5) 
and after sham-operation (lane 6).  
 
Figure 3. Immunohistochemical detection of KGF and KGFR in remnant lung after 
trilobectomy 
The expression of KGF (A, B and E) and KGFR (C, D and F) was detected by 
immunohistochemistry. (A) Alveolar part at day 4 after trilobectomy. (B) Alveolar part at 
day 4 after sham-operation. (C) Alveolar part at day 4 after trilobectomy. (D) Alveolar 
 
part at day 4 after sham-operation. (E) Bronchial part at day 4 after trilobectomy. (F) 
Bronchial part at day 4 after trilobectomy. Magnification: x400. Bar: 50 μm. (G) Serial 
changes in the signal density of KGF staining in trilobectomy group (n=3) (open circles) 
and sham-operation group (n=3) (closed circles). (H) Serial changes in the signal density 
of KGFR staining in trilobectomy group (n=3) (open circles) and sham-operation group 
(n=3) (closed circles).  
  
Figure 4. Immunohistochemical detection of KGF, KGFR and PCNA in serial 
sections of remnant lung at day 4 after trilobectomy. 
(A) H&E staining. (B) KGF was detected in the cytoplasm of alveolar epithelial cells. (C) 
PCNA staining. (D) KGFR was detected in the plasma membrane of alveolar epithelial 
cells. PCNA-positive alveolar type II cells are identical, at least in part, to KGF- and 
KGFR-double positive cells (arrows). Bar: 25 μm. 
 
Figure 5. KGF protein production, DNA synthesis and cell proliferation in cell 
medium and lysate transfected with pKGF-FLAG gene and pFLAG gene. 
(A) The concentrations of KGF in the medium and lysates of L2 cells transfected with 
pKGF-FLAG gene and pFLAG gene were measured at 24, 48 and 72 hour after 
transfection. KGF concentration in the medium of L2 cells transfected with pKGF-FLAG 
gene increased in a time-dependent manner. (B) DNA synthesis and (C) cell proliferation 
of L2 cells transfected with pKGF-FLAG and pFLAG. L2 cells were transfected by 
 
electroporation, cultured for 24, 48 and 72 hours, and subsequently assessed for BrdU 
uptake as well as the number of cells per well. There were significant differences in BrdU 
uptake between pKGF-FALG gene and pFLAG gene at 24 and 48 hours after transfection. 
There was also a significant difference in the cell number between pKGF-FALG gene 
and pFLAG gene at 72 hours after transfection. 
 
Figure 6. Effects of pKGF-FLAG gene and pFLAG gene expression on 
PCNA-positive cells at day 4 after electroporative transfection. 
(A and B) Immunohistochemistry for PCNA in the alveolar part of remnant lung 
transfected with pFLAG gene (A) or pKGF-FLAG gene (B). In adjacent sections of the 
alveolar part transfected with pKGF-FLAG gene, one section (C) was used for the 
deletion of FLAG (KGF-FLAG) and another (D) was stained for PCNA expression. 
Magnification: x400. Bar: 50 μm. (E) Serial changes in PCNA labeling index. Open bars: 
group transfected with pFLAG gene (n=5), closed bars: group transfected with 
pKGF-FLAG gene (n=5) (*p<0.05). (F) Mean linear intercept values measured in 
remnant lung transfected with pFLAG gene or pKGF-FLAG gene. Values are 
mean±SEM. * P<0.001, for comparison of Lm of remnant lung transfected with 
pKGF-FLAG gene and that with pFLAG gene. 
 
Figure 7. Double staining for PCNA and Surfactant Protein-A at day 4 after 
transfection in alveolar part of remnant lung transfected with pKGF-FLAG gene.  
Double staining for PCNA (blue) and SP-A (brown). The majority of PCNA-positive 
 
cells were epithelial cells. Arrows: alveolar type II cells, arrowhead: type I cells. 
Magnification: x400. Bar: 25 μm. 
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